| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/FJC.0B013E31823827A4 |
| P953 | full work available online at | http://journals.lww.com/00005344-201202000-00004 |
| P698 | PubMed publication ID | 21964158 |
| P2093 | author name string | Peter Mark Oroma Owira | |
| Sphilile Xulu | |||
| P2860 | cites work | Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance | Q24648189 |
| A simple method for the isolation and purification of total lipides from animal tissues | Q25939009 | ||
| Changes in plasma lipid and antioxidant activity in rats as a result of naringin and red grapefruit supplementation | Q28244821 | ||
| Hypoglycemic effect of the water extract of Smallantus sonchifolius (yacon) leaves in normal and diabetic rats | Q31889581 | ||
| Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association | Q33728882 | ||
| Influence of proteinuria on vascular disease, blood pressure, and lipoproteins in insulin dependent diabetes mellitus | Q34070803 | ||
| Atherogenic dyslipidemia: cardiovascular risk and dietary intervention | Q34180234 | ||
| 'Lipoproteins, glycoxidation and diabetic angiopathy'. | Q35877289 | ||
| Flavonols, flavones, flavanones, and human health: epidemiological evidence | Q36263492 | ||
| Lipids and lipoproteins as coronary risk factors in non-insulin-dependent diabetes mellitus | Q41556858 | ||
| Management of Dyslipidemia in Adults With Diabetes | Q41737048 | ||
| RG 12561 (dalvastatin): a novel synthetic inhibitor of HMG-CoA reductase and cholesterol-lowering agent | Q42289323 | ||
| More Intensive Lipid Lowering is Associated with Regression of Coronary Atherosclerosis in Diabetic Patients with Acute Coronary Syndrome –Sub-Analysis of JAPAN-ACS Study | Q42950118 | ||
| Does eicosapentaenoic acid truly reduce atherosclerosis? | Q43274966 | ||
| Naringenin enhances insulin-stimulated tyrosine phosphorylation and improves the cellular actions of insulin in a dietary model of metabolic syndrome | Q43281564 | ||
| Naringin Has an Antiatherogenic Effect With the Inhibition of Intercellular Adhesion Molecule-1 in Hypercholesterolemic Rabbits | Q43798821 | ||
| The plastid transcription kinase from mustard (Sinapis alba L.). A nuclear-encoded CK2-type chloroplast enzyme with redox-sensitive function | Q44041434 | ||
| Naringin supplementation lowers plasma lipids and enhances erythrocyte antioxidant enzyme activities in hypercholesterolemic subjects | Q44652992 | ||
| Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. | Q44689759 | ||
| Naringin alters the cholesterol biosynthesis and antioxidant enzyme activities in LDL receptor-knockout mice under cholesterol fed condition | Q44738720 | ||
| Antihypercholesterolemic property of naringin alters plasma and tissue lipids, cholesterol-regulating enzymes, fecal sterol and tissue morphology in rabbits | Q45068849 | ||
| Small, dense low-density lipoproteins (LDL) are predictors of cardio- and cerebro-vascular events in subjects with the metabolic syndrome | Q46389694 | ||
| Circulating oxidized LDL, measured with FOH1a/DLH3 antibody, is associated with metabolic syndrome and the coronary heart disease risk score in healthy Japanese | Q46478040 | ||
| Antidiabetic and toxicological evaluations of naringenin in normoglycaemic and NIDDM rat models and its implications on extra-pancreatic glucose regulation. | Q46691031 | ||
| Combined treatment with naringin and vitamin C ameliorates streptozotocin-induced diabetes in male Wistar rats | Q46698985 | ||
| Effect of citrus flavonoids on lipid metabolism and glucose-regulating enzyme mRNA levels in type-2 diabetic mice | Q46904894 | ||
| Green tea extract impedes dyslipidaemia and development of cardiac dysfunction in streptozotocin-diabetic rats | Q50703774 | ||
| Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investiga | Q51566349 | ||
| Naringin time-dependently lowers hepatic cholesterol biosynthesis and plasma cholesterol in rats fed high-fat and high-cholesterol diet | Q53581499 | ||
| Micro assay for 3-hydroxy-3-methylglutaryl-CoA reductase in rat liver and in L-cell fibroblasts | Q53717225 | ||
| The hypoglycemic effects of hesperidin and naringin are partly mediated by hepatic glucose-regulating enzymes in C57BL/KsJ-db/db mice. | Q55039250 | ||
| Regulation of acyl-CoA:cholesterol acyltransferase activity in normal and atherosclerotic rabbit aortas: role of a cholesterol substrate pool | Q69545871 | ||
| The effects of simvastatin and cholestyramine, alone and in combination, on hepatic cholesterol metabolism in the male rat. off | Q70828706 | ||
| Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) | Q73209707 | ||
| Preventive effect of naringin on lipids, lipoproteins and lipid metabolic enzymes in isoproterenol-induced myocardial infarction in Wistar rats | Q80103449 | ||
| Dietary naringenin increases hepatic peroxisome proliferators-activated receptor α protein expression and decreases plasma triglyceride and adiposity in rats | Q84453550 | ||
| Effects of naringin and lovastatin on plasma and hepatic lipids in high-fat and high-cholesterol fed rats | Q127012814 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | type-1 diabetes | Q124407 |
| hyperglycemia | Q271993 | ||
| atherosclerosis | Q12252367 | ||
| atherogenic dyslipidemia | Q16534561 | ||
| dyslipidemia | Q66291209 | ||
| P304 | page(s) | 133-141 | |
| P577 | publication date | 2012-02-01 | |
| P1433 | published in | Journal of Cardiovascular Pharmacology | Q2125808 |
| P1476 | title | Naringin ameliorates atherogenic dyslipidemia but not hyperglycemia in rats with type 1 diabetes | |
| Naringin Ameliorates Atherogenic Dyslipidemia but not Hyperglycemia in Rats With Type 1 Diabetes | |||
| P478 | volume | 59 |
| Q92839136 | Combined application of Doxorubicin and Naringin enhances the antitumor efficiency and attenuates the toxicity of Doxorubicin in HeLa cervical cancer cells |
| Q35988288 | Grapefruit Derived Flavonoid Naringin Improves Ketoacidosis and Lipid Peroxidation in Type 1 Diabetes Rat Model |
| Q46828685 | Grapefruit juice improves glucose intolerance in streptozotocin-induced diabetes by suppressing hepatic gluconeogenesis |
| Q46911127 | Grapefruit: Some perspectives in pharmacology and nutrition |
| Q47980776 | Identification of Naringin Metabolites in Human Urine and Feces |
| Q35953912 | Naringin Reduces Hyperglycemia-Induced Cardiac Fibrosis by Relieving Oxidative Stress |
| Q40862731 | Naringin Reverses Hepatocyte Apoptosis and Oxidative Stress Associated with HIV-1 Nucleotide Reverse Transcriptase Inhibitors-Induced Metabolic Complications |
| Q40744532 | Naringin improves zidovudine- and stavudine-induced skeletal muscle complications in rats |
| Q39149078 | Naringin inhibits growth potential of human triple-negative breast cancer cells by targeting β-catenin signaling pathway |
| Q43865605 | Naringin prevents HIV-1 protease inhibitors-induced metabolic complications in vivo |
| Q64248657 | Preventive Effect of Naringin on Metabolic Syndrome and Its Mechanism of Action: A Systematic Review |
| Q36331862 | Retracted: Naringin Alleviates Diabetic Kidney Disease through Inhibiting Oxidative Stress and Inflammatory Reaction |
Search more.